3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Glioma
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Astrocytoma
3
Sarcoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Rhabdomyosarcoma
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pilonidal Sinus
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
pembrolizumab
1
neratinib
1
cemiplimab
1
brigatinib
1
Watchful Waiting
1
Vincristine
1
Vemurafenib
1
Temozolomide
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.